321-38-0

Applied Filters:

Keyword:'321-38-0'

Showing 1-2 of 2 results for "321-38-0" within Papers

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis.

Jessica L Mega et al.

Lancet (London, England), 376(9749), 1312-1319 (2010-08-31)

Clopidogrel and prasugrel are subject to efflux via P-glycoprotein (encoded by ABCB1, also known as MDR1). ABCB1 polymorphisms, particularly 3435C→T, may affect drug transport and efficacy. We aimed to assess the effect of this polymorphism by itself and alongside variants

Adrenocorticotropic hormone and cortisol in calves after corticotropin-releasing hormone.

I Veissier et al.

Journal of animal science, 77(8), 2047-2053 (1999-08-26)

The aim for this study was to analyze responsiveness of the hypothalamo-pituitary-adrenocortical axis to exogenous bovine corticotropin-releasing hormone (bCRH) in calves. Two dose-response studies were carried out, using either bCRH alone (dose rates of 0, .01, .03, and .1 microg

Page 1 of 1